Showing results (11-20 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|February 20, 2019
Challenge model of TNFα turnover at varying LPS and drug provocationsFelix Held, Edmund Hoppe, Marija Cvijovic, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 17, 2018
Benchmarking renin suppression and blood pressure reduction of direct renin inhibitor imarikiren through quantitative systems pharmacology modelingYeshitila Gebremichael, Gezim Lahu, Majid Vakilynejad, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 7, 2019
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patientsSophie E Berends, Tamara J van Steeg, Maurice J Ahsman, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 4, 2021
A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapyJoost DeJongh, Maurice Ahsman, Nelleke SnelderJournal of Pharmacokinetics and Pharmacodynamics|January 6, 2022
From data to QSP models: a pipeline for using Boolean networks for hypothesis inference and dynamic model buildingM Putnins, O Campagne, D E Mager, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 22, 2019
Structural identifiability and sensitivityAthanassios IliadisJournal of Pharmacokinetics and Pharmacodynamics|June 21, 2011
Bounded outcome score modeling: application to treating psoriasis with ustekinumabChuanpu Hu, Newman Yeilding, Hugh M Davis, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 18, 2011
Population pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritisDongyang Liu, Hoi-Kei Lon, Debra C Dubois, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 23, 2011
Potential errors in the volume of distribution estimation of therapeutic proteins composed of differently cleared componentsWolfgang F Richter, Hans Peter Grimm, Frank-Peter TheilJournal of Pharmacokinetics and Pharmacodynamics|August 23, 2011
Modelling of the outcome of non-inferiority trials by integration of historical dataAlberto Russu, Erik van Zwet, Giuseppe De Nicolao, et al.Pageof 107